Literature DB >> 25213096

Linear mixed-effects models for central statistical monitoring of multicenter clinical trials.

L Desmet1, D Venet, E Doffagne, C Timmermans, T Burzykowski, C Legrand, M Buyse.   

Abstract

Multicenter studies are widely used to meet accrual targets in clinical trials. Clinical data monitoring is required to ensure the quality and validity of the data gathered across centers. One approach to this end is central statistical monitoring, which aims at detecting atypical patterns in the data by means of statistical methods. In this context, we consider the simple case of a continuous variable, and we propose a detection procedure based on a linear mixed-effects model to detect location differences between each center and all other centers. We describe the performance of the procedure as a function of contamination rate and signal-to-noise ratio. We investigate the effect of center size and variance structure and illustrate the use of the procedure using data from two multicenter clinical trials.
Copyright © 2014 John Wiley & Sons, Ltd.

Keywords:  contamination rate; error detection; linear mixed-effects model; multicenter clinical trial; signal-to-noise ratio; statistical monitoring

Mesh:

Year:  2014        PMID: 25213096     DOI: 10.1002/sim.6294

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  9 in total

Review 1.  Data-driven risk identification in phase III clinical trials using central statistical monitoring.

Authors:  Catherine Timmermans; David Venet; Tomasz Burzykowski
Journal:  Int J Clin Oncol       Date:  2015-08-02       Impact factor: 3.402

Review 2.  The impact of clinical trial monitoring approaches on data integrity and cost--a review of current literature.

Authors:  Rasmus Olsen; Asger Reinstrup Bihlet; Faidra Kalakou; Jeppe Ragnar Andersen
Journal:  Eur J Clin Pharmacol       Date:  2016-01-04       Impact factor: 2.953

3.  Data fraud in clinical trials.

Authors:  Stephen L George; Marc Buyse
Journal:  Clin Investig (Lond)       Date:  2015

Review 4.  Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT Recommendations.

Authors:  Jennifer S Gewandter; Robert H Dworkin; Dennis C Turk; Eric G Devine; David Hewitt; Mark P Jensen; Nathaniel P Katz; Amy A Kirkwood; Richard Malamut; John D Markman; Bernard Vrijens; Laurie Burke; James N Campbell; Daniel B Carr; Philip G Conaghan; Penney Cowan; Mittie K Doyle; Robert R Edwards; Scott R Evans; John T Farrar; Roy Freeman; Ian Gilron; Dean Juge; Robert D Kerns; Ernest A Kopecky; Michael P McDermott; Gwendolyn Niebler; Kushang V Patel; Richard Rauck; Andrew S C Rice; Michael Rowbotham; Nelson E Sessler; Lee S Simon; Neil Singla; Vladimir Skljarevski; Tina Tockarshewsky; Geertrui F Vanhove; Ajay D Wasan; James Witter
Journal:  J Pain       Date:  2019-12-13       Impact factor: 5.820

Review 5.  Design and conduct of confirmatory chronic pain clinical trials.

Authors:  Nathaniel Katz
Journal:  Pain Rep       Date:  2020-12-18

6.  Bayesian central statistical monitoring using finite mixture models in multicenter clinical trials.

Authors:  Tomoyoshi Hatayama; Seiichi Yasui
Journal:  Contemp Clin Trials Commun       Date:  2020-04-09

7.  Effects of an exercise program on hepatic metabolism, hepatic fat, and cardiovascular health in overweight/obese adolescents from Bogotá, Colombia (the HEPAFIT study): study protocol for a randomized controlled trial.

Authors:  Katherine González-Ruíz; Jorge Enrique Correa-Bautista; Mikel Izquierdo; Antonio García-Hermoso; María Andrea Dominguez-Sanchez; Rosa Helena Bustos-Cruz; Jorge Cañete García-Prieto; Vicente Martínez-Vizcaíno; Felipe Lobelo; Emilio González-Jiménez; Daniel Humberto Prieto-Benavides; Alejandra Tordecilla-Sanders; Jacqueline Schmidt-RioValle; Guillermo Perez; Robinson Ramírez-Vélez
Journal:  Trials       Date:  2018-06-25       Impact factor: 2.279

Review 8.  Central statistical monitoring of investigator-led clinical trials in oncology.

Authors:  Marc Buyse; Laura Trotta; Everardo D Saad; Junichi Sakamoto
Journal:  Int J Clin Oncol       Date:  2020-06-23       Impact factor: 3.402

Review 9.  Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review.

Authors:  William J Cragg; Caroline Hurley; Victoria Yorke-Edwards; Sally P Stenning
Journal:  Clin Trials       Date:  2021-02-20       Impact factor: 2.486

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.